Pages that link to "Q41604304"

The following pages link to How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. (Q41604304):

Displaying 29 items.

• Vitrification versus slow freezing for women undergoing oocyte cryopreservation (Q24193770) (← links)
• Utility of antioxidants during assisted reproductive techniques: an evidence based review (Q27023797) (← links)
• Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance (Q28077375) (← links)
• The efficiency of a donor-recipient program using infertile donors' egg cryo-banking: a Brazilian reality (Q34037236) (← links)
• Comparison of the Developmental Potential and Clinical Results of In Vivo Matured Oocytes Cryopreserved with Different Vitrification Media (Q36695958) (← links)
• Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue (Q36957618) (← links)
• Who benefits from putting family life into ice? (Q37397737) (← links)
• Assisted reproductive technology results: why are live-birth percentages so low? (Q38210367) (← links)
• Oocyte cryopreservation: where are we now? (Q38785749) (← links)
• Improved cryotolerance and developmental potential of in vitro and in vivo matured mouse oocytes by supplementing with a glutathione donor prior to vitrification (Q39413339) (← links)
• Closed oocyte vitrification and storage in an oocyte donation programme: obstetric and neonatal outcome. (Q39952028) (← links)
• Closed vitrification of human oocytes and blastocysts: outcomes from a series of clinical cases. (Q41011702) (← links)
• Hydroxypropyl cellulose supplementation in vitrification solutions: a prospective study with donor oocytes. (Q41597734) (← links)
• Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013. (Q41597942) (← links)
• Oocyte vitrification does not affect early developmental timings after intracytoplasmic sperm injection for women younger than 30 years old. (Q41598716) (← links)
• Usefulness of oocyte accumulation in low ovarian response for PGS. (Q41599423) (← links)
• Comparative efficiency study of fresh and vitrified oocytes in egg donation programs for different controlled ovarian stimulation protocols (Q41602063) (← links)
• RNA-Seq transcriptome profiling of mouse oocytes after in vitro maturation and/or vitrification (Q42378958) (← links)
• Cancer and fertility preservation: international recommendations from an expert meeting (Q43106184) (← links)
• Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series (Q46134112) (← links)
• A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos (Q47319454) (← links)
• The use of portable CO2 incubator for cross-border shipping of embryos in an international egg donation program (Q48599894) (← links)
• Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. (Q52675519) (← links)
• Fertility preservation in transgender patients (Q55952194) (← links)
• Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives (Q57093082) (← links)
• Progress in Fertility Preservation Strategies in Turner Syndrome (Q89623429) (← links)
• Human oocytes and zygotes are ready for ultra-fast vitrification after 2 minutes of exposure to standard CPA solutions (Q91129984) (← links)
• [Causes of oocyte vitrification and its value in assisted reproductive technology] (Q92152289) (← links)
• Immature Oocyte for Fertility Preservation (Q92404245) (← links)